Accordingly, PTPN22 is considered as the main non-HLA genetic risk factor involved in RA pathogenesis11, and, in fact, PTPN22 expression profiles have been proposed as biomarkers of RA8–10. This evidence concerns the gene PTPN22 and rheumatoid arthritis.